Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance
Reference number: TA161
Published: 27 October 2008
Last updated: 07 February 2018

Osteoporosis - secondary prevention including strontium ranelate: Decision Support Unit (DSU) report

Osteoporosis - secondary prevention including strontium ranelate: DSU specification
Osteoporosis - secondary prevention including strontium ranelate: DSU report
Osteoporosis - secondary prevention including strontium ranelate: Servier response to DSU report

This page was last updated: 06 December 2010